B. Naser-Hijazi

Prophylaxis of radiogenic sialadenitis and mucositis by coumarin/troxerutine in patients with head and neck cancer – a prospective,randomized, placebo-controlled, double-blind study

K. A. Grötz, P W Wüstenberg, Ralf Kohnen et al. · British Journal of Oral and Maxillofacial Surgery · 2001 · 56 citations

Medicine, Oncology, Radiation Oncology +16

Safety aspects of a coumarin-troxerutin combination regarding liver function in a double-blind placebo-controlled study

H. J. Schmeck-Lindenau, B. Naser-Hijazi, Wendy S. Becker et al. · International Journal of Clinical Pharmacology and Therapeutics · 2003 · 34 citations

Pharmacy, Pharmacology, Pharmacotherapy +9

Locoregional administration of 5-fluoro-2′-deoxyuridine (FdUrd) in Novikoff hepatoma in the rat: effects of dose and infusion time on tumor growth and on FdUrd metabolite levels in tumor tissue as determined by19F-NMR spectroscopy

B. Naser-Hijazi, Martin R. Berger, D. Schmähl et al. · Journal of Cancer Research and Clinical Oncology · 1991 · 28 citations · Full text

Medicine, Oncology, Pharmacokinetics +17

Single copy of variant CYP2A6 alleles does not confer susceptibility to liver dysfunction in patients treated with coumarin

Maria Burian, Johannes Freudenstein, M. Tegtmeier et al. · International Journal of Clinical Pharmacology and Therapeutics · 2003 · 28 citations

Medicine, Pharmacology, Molecular Pharmacology +16

Fluoropyrimidine chemotherapy in a rat model: comparison of fluorouracil metabolite profiles determined by high‐field ¹⁹F‐NMR spectroscopy of tissues <i>ex vivo</i> with therapy response and toxicity for locoregional vs systemic infusion protocols

Norbert W. Lutz, B. Naser-Hijazi, Squire Koroma et al. · NMR in Biomedicine · 2004 · 16 citations

Medicine, Oncology, Pharmacology +17